Trials Offered by a Specific Doctor

Alice Lee, MD

Alice Lee, MD specializes in the care of children and adolescents with solid tumors, especially neuroblastoma, Wilms' tumor, and sarcomas. She also conducts research to develop and evaluate new anticancer therapies for young patients.

Dr. Lee takes a personal interest in her patients. She says, "The patients I care for are amazing. Regardless of how a child is doing during treatment, they just want to be kids. I form bonds with their families that are rich and lifelong. They come to us each day hoping their children get better, while we come to work each day hoping to advance the field with more effective therapies so more children get better. My goal is to know I've done all we can for every one of our patients, and to further therapy by developing new anticancer drugs that become a standard part of care for pediatric cancers in the future."

Dr. Lee is also intrigued by the science of pediatric oncology. In this ever-changing field, much remains to be learned, which offers her an intellectual challenge. As the institution's principal investigator for the Children's Oncology Group (COG; the nation's leading pediatric cancer research consortium), Dr. Lee and her team are evaluating new therapies and new combinations of existing therapies to identify more effective, less toxic treatments for children with cancer.

Dr. Lee is proud to be part of the team at NewYork-Presbyterian/Morgan Stanley Children's Hospital at Columbia University Medical Center, where patients have all the specialists they may need in one location, including pediatric critical care onsite if serious complications arise. Her division has leaders in every type of pediatric cancer or blood disorder.

Clinical Studies Managed By Dr. Lee:
More InfoTitleSponsorIRB Number
DetailsA study for children with acute lymphoblastic leukemia using study drug carfilzomibAmgenAAAO2351
DetailsA study in children, adolescents, and young adults recurrent or refractory solid tumors using study drug nivolumabCHOPAAAP1101
Details[CLOSED] A study for children and adolescents with relapsed or refractory acute myeloid leukemia using study drug LenalidomideChildren's Hospital of PhiladelphiaAAAP9858
Details[CLOSED] A study for children with high-risk neuroblastoma using study drug unituxinUnited Therapeutics Corp.AAAQ6521
Details[CLOSED] A study for children with refractory solid tumors, including CNS tumors using study drug ramucirumabEli Lilly and CompanyAAAQ5801
DetailsA study for patients with advanced melanoma, solid tumors or lymphoma using study drug PembrolizumabMerck Sharp & Dohme Corp.AAAQ7819
Details[CLOSED] A study to Assess Safety and Effectiveness of Study Drug OTO-104 in Patients at Risk of Hearing Loss From Cisplatin ChemotherapyOtonomyAAAR0729
Details[CLOSED] Study of New Drug with Radiation Therapy in Children with Diffuse Intrinsic Pontine Gliomas (DIPG) Brain Stem CancerChildren's Oncology GroupAAAM3003
DetailsStudy of Selinexor in Pediatric Solid Tumors, including CNS TumorsChildren's Oncology GroupAAAQ4204
DetailsTesting combination drugs in children with solid tumors that have come back or are resistant to current anti-cancer therapyChildren's Oncology GroupAAAR6731
DetailsStudy of Entinostat in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS Tumors and LymphomaChildren's Oncology GroupAAAR2008
Details[CLOSED] Study of Drug in Pediatric Patients with Recurrent or Refractory Solid Tumors, including CNS TumorsChildren's Oncology GroupAAAR3155
DetailsStudy of Combination of Drugs in Recurrent and Refractory Pediatric Solid Tumors, Including CNS TumorsChildren's Oncology GroupAAAR4705
DetailsStudy of Experimental Drug in Pediatric Patients with Solid Tumors, including CNS TumorsChildren's Oncology GroupAAAR5342
DetailsStudy of MK-1775 in Combination with Irinotecan in Children, Adolescents, and Young Adults with Relapsed or Refractory Solid TumorChildren's Oncology Group COGAAAN4703
DetailsStudy of VX15/2508 in Children, Adolescents, or Young Adults with Recurrent or Relapsed Solid TumorsChildren's Oncology Group COGAAAR7408
DetailsEribulin Mesylate in Pediatric Subjects with Rhabdomyosarcoma (RMS), non-Rhabdomyosarcoma Soft Tissue Sarcoma(NRSTS) and Ewing Sarcoma(EWS)EisaiAAAS0709
DetailsPalbociclib and Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)Children's Oncology GroupAAAS2612
DetailsSafety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (6 months-17 years)BayerAAAR7789
DetailsSafety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (ages 18-21)BayerAAAR7789
DetailsStudy Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerAAAS2961